Rocket Pharmaceuticals Announces Positive Updates from Phase 1 Clinical Trial of RP-A501 in Danon DiseaseBusiness Wire • 11/15/21
Rocket Pharmaceuticals to Host Webcast on Nov. 15 at 8:30 a.m. ET to Present Updated Danon Disease Clinical DataBusiness Wire • 11/11/21
Rocket Pharmaceuticals Announces Participation in Stifel 2021 Virtual Healthcare ConferenceBusiness Wire • 11/10/21
Rocket Pharmaceuticals Announces Danon Disease Presentation at the American Heart Association (AHA) Scientific Sessions 2021Business Wire • 11/08/21
Rocket Pharmaceuticals Announces Presentations Highlighting Three Lentiviral Gene Therapies at the 63rd American Society of Hematology (ASH) Annual MeetingBusiness Wire • 11/04/21
Rocket Pharmaceuticals Reports Third Quarter 2021 Financial Results and Highlights Recent ProgressBusiness Wire • 11/03/21
Rocket Pharma Posts Interim Data From Immunodeficiency Disorder Gene Therapy TrialBenzinga • 10/20/21
Rocket Pharmaceuticals Announces Positive Clinical Data from RP-L201 Trial for the Treatment of LAD-I at the 28th Annual Congress of the European Society of Gene & Cell Therapy (ESGCT)Business Wire • 10/20/21
Rocket Pharmaceuticals Announces Presentations Highlighting Lentiviral Gene Therapies at the 28th Annual Congress of the European Society of Gene & Cell Therapy (ESGCT)Business Wire • 10/19/21
Rocket Pharmaceuticals to Present at the 2021 Cell & Gene Meeting on the MesaBusiness Wire • 10/07/21
Rocket Pharmaceuticals Stock Forecast: Can It Rebound To $50 Levels? A Resounding YesSeeking Alpha • 10/01/21
Rocket Pharmaceuticals to Participate in the Chardan Virtual 5th Annual Genetic Medicines ConferenceBusiness Wire • 09/30/21
Rocket Pharmaceuticals Presents Clinical Data from RP-A501 Trial in Danon Disease at the Heart Failure Society of America (HFSA) Annual Scientific Meeting 2021Business Wire • 09/14/21
Rocket Pharmaceuticals Announces Upcoming Danon Disease Presentation at the Heart Failure Society of America Annual Scientific Meeting 2021Business Wire • 09/10/21
Rocket Pharmaceuticals Appoints Isabel Carmona, J.D., as Chief Human Resources OfficerBusiness Wire • 09/07/21
Rocket Pharmaceuticals Announces FDA Lifts Clinical Hold on Danon Disease Trial of RP-A501Business Wire • 08/16/21
Rocket Pharmaceuticals, Inc. (RCKT) CEO Gaurav Shah on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 08/10/21
Rocket Pharmaceuticals Reports Second Quarter 2021 Financial Results and Highlights Recent ProgressBusiness Wire • 08/09/21
Rocket Pharmaceuticals to Host Conference Call on Aug. 9 at 4:30 p.m. ET to Discuss Second Quarter Results and Recent Business HighlightsBusiness Wire • 08/03/21
Rocket Pharmaceuticals Announces Positive Data From RP-L102, RP-L201 Gene Therapy ProgramsBenzinga • 05/13/21
Rocket Pharmaceuticals Presents Positive Clinical Data from Fanconi Anemia, Leukocyte Adhesion Deficiency-I, and Pyruvate Kinase Deficiency Programs at 24th Annual Meeting of the American Society of Gene and Cell TherapyBusiness Wire • 05/13/21